472 related articles for article (PubMed ID: 15611429)
1. Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma.
Seishima M; Oda M; Oyama Z; Yoshimura T; Yamazaki F; Aoki T; Nei M; Hashimoto T
Arch Dermatol; 2004 Dec; 140(12):1500-3. PubMed ID: 15611429
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
3. Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus.
Ohyama M; Amagai M; Hashimoto T; Nousari HC; Anhalt GJ; Nishikawa T
J Am Acad Dermatol; 2001 Apr; 44(4):593-8. PubMed ID: 11260531
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
[TBL] [Abstract][Full Text] [Related]
5. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.
Nguyen VT; Ndoye A; Bassler KD; Shultz LD; Shields MC; Ruben BS; Webber RJ; Pittelkow MR; Lynch PJ; Grando SA
Arch Dermatol; 2001 Feb; 137(2):193-206. PubMed ID: 11176692
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus.
Wang J; Bu DF; Li T; Zheng R; Zhang BX; Chen XX; Zhu XJ
Br J Dermatol; 2005 Sep; 153(3):558-64. PubMed ID: 16120143
[TBL] [Abstract][Full Text] [Related]
7. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
8. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
9. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic pemphigus with circulating antibodies directed exclusively against the pemphigus vulgaris antigen desmoglein 3.
Bouloc A; Joly P; Saint-Leger E; Wechsler J; Roujeau JC; Revuz J
J Am Acad Dermatol; 2000 Oct; 43(4):714-7. PubMed ID: 11004638
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic pemphigus.
Zhu X; Zhang B
J Dermatol; 2007 Aug; 34(8):503-11. PubMed ID: 17683379
[TBL] [Abstract][Full Text] [Related]
12. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
13. Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies.
Mimouni D; Foedinger D; Kouba DJ; Orlow SJ; Rappersberger K; Sciubba JJ; Nikolskaia OV; Cohen BA; Anhalt GJ; Nousari CH
J Am Acad Dermatol; 2004 Jul; 51(1):62-7. PubMed ID: 15243525
[TBL] [Abstract][Full Text] [Related]
14. Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus.
Li J; Bu DF; Huang YC; Zhu XJ
Chin Med J (Engl); 2009 Mar; 122(5):486-95. PubMed ID: 19323896
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of alopecia in patients with paraneoplastic pemphigus].
Zuo YG; Wang BX; Ma DL; Cao BQ; Zhao JH; Guo Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):354-6. PubMed ID: 16038274
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic pemphigus mimicking erosive mucosal lichen planus associated with primary hepatocellular carcinoma.
Yokokura H; Demitsu T; Kakurai M; Umemoto N; Azuma R; Yamada T; Suzuki M; Jimbu Y; Yoneda K; Ishii N; Hashimoto T
J Dermatol; 2006 Dec; 33(12):842-5. PubMed ID: 17169086
[TBL] [Abstract][Full Text] [Related]
17. Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay.
Mouquet H; Drenovska K; Lartigue A; Joly P; Drouot L; Thomas M; Tron F; Gilbert D
Clin Immunol; 2008 Nov; 129(2):304-12. PubMed ID: 18790674
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic pemphigus in children and adolescents.
Mimouni D; Anhalt GJ; Lazarova Z; Aho S; Kazerounian S; Kouba DJ; Mascaro JM; Nousari HC
Br J Dermatol; 2002 Oct; 147(4):725-32. PubMed ID: 12366419
[TBL] [Abstract][Full Text] [Related]
19. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
[TBL] [Abstract][Full Text] [Related]
20. ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.
Abasq C; Mouquet H; Gilbert D; Tron F; Grassi V; Musette P; Joly P
Arch Dermatol; 2009 May; 145(5):529-35. PubMed ID: 19451496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
